The Default Mode Network and How Ketamine Treats Depression

The default mode network and depression are closely linked through a specific brain circuit that becomes overactive and rigid in people with major depressive disorder. The default mode network (DMN) is a set of interconnected brain regions, including the medial prefrontal cortex, posterior cingulate cortex, and angular gyrus, that activates when the mind is at rest and turns inward toward self-reflection, memory, and daydreaming. In depression, this network becomes hyperactive and overly connected, locking the brain into repetitive, self-critical thought patterns known as rumination. Ketamine has been shown in neuroimaging studies to acutely disrupt this pathological DMN activity, loosening its rigid connectivity and reducing activity in the regions tied to negative self-focus. This disruption is one of the leading neurobiological explanations for how ketamine produces rapid antidepressant effects, particularly in patients with treatment-resistant depression who have not responded to conventional antidepressants.

Anatomy of the Default Mode Network

The DMN is made up of several regions that consistently activate together during rest and self-referential thought. For a broader definition of this term, see our default mode network glossary entry.

• Medial prefrontal cortex (mPFC): Handles self-evaluation and social cognition. Overactivity here is linked to excessive self-critical thinking in depression.
• Posterior cingulate cortex (PCC) and precuneus: Central hubs involved in autobiographical memory and self-orientation. The PCC is one of the most metabolically active regions of the resting brain.
• Angular gyrus: Supports semantic processing and the integration of sensory and conceptual information.
• Medial temporal lobe, including the hippocampus: Contributes autobiographical memories to the self-referential processing stream.

These regions form a coherent network through functional connectivity, meaning their activity rises and falls in correlated patterns. Researchers measure this connectivity using functional magnetic resonance imaging (fMRI), a technique that tracks blood flow changes to infer neural activity, and these measurements have become a central tool for studying depression's neurobiology.

How the DMN Functions in a Healthy Brain

In people without depression, the DMN supports several essential functions: maintaining a consistent sense of identity over time, supporting social cognition and theory of mind, contributing to creative problem-solving through mind-wandering, and helping process emotional experience through self-reflection.

The key difference in a healthy brain is flexibility. The DMN deactivates smoothly when attention shifts to an external task, allowing dynamic switching between the DMN and task-positive networks such as the dorsal attention network and the central executive network. This switching lets a person move fluidly between internal reflection and external engagement.

The DMN in Depression

Hyperactivation

Functional neuroimaging studies consistently show the DMN is hyperactive in people with major depression. The self-referential processing system stays chronically switched on, generating a continuous stream of internally directed, self-focused thought even during attempts to engage with the outside world.

Hyperconnectivity

The connections within the DMN also run excessively strong in depression. This hyperconnectivity creates a tightly coupled network that resists modulation, so the network stays activated even when other brain systems should take over.

Impaired Deactivation

One of the most clinically significant abnormalities is the DMN's failure to deactivate during task engagement. Healthy brains show strong DMN suppression when a cognitive task begins. In depression, that suppression is incomplete, so the self-referential stream keeps running in the background, intruding on attention and reinforcing negative self-focused thinking.

Rumination: The Clinical Consequence of DMN Overactivity

Rumination, the repetitive, passive focus on one's distress, its causes, and its consequences, is the primary clinical expression of DMN hyperactivity in depression. It typically involves repetitive thinking about past failures or losses, self-critical evaluation, passive analysis instead of active problem-solving, difficulty redirecting attention, and a sense of being mentally trapped in negative thought loops.

According to the National Institute of Mental Health, depression involves measurable disruptions in brain circuits governing mood, cognition, and self-referential thought, consistent with the rumination patterns tied to DMN dysfunction.

Rumination is not simply a symptom, it is a maintenance factor that perpetuates depressive episodes. It amplifies negative mood, interferes with problem-solving, erodes social support as people withdraw from engagement, and delays recovery. Interventions that reduce rumination, such as mindfulness-based cognitive therapy, have been shown to help prevent depressive relapse. The link between DMN hyperactivity and rumination gives researchers a specific neurobiological target for treatment, which is part of why ketamine's disruption of the DMN is significant for patients with treatment-resistant depression who have not responded to conventional antidepressants targeting serotonin and norepinephrine.

How Ketamine Disrupts the DMN

Acute Effects During Treatment

Neuroimaging studies using fMRI and related techniques have documented several ketamine effects on the DMN during and shortly after infusion:

• Reduced within-network connectivity: The tight coupling between DMN regions loosens, disrupting the self-referential processing stream.
• Increased between-network connectivity: The boundaries between the DMN and other brain networks become more permeable, allowing more flexible cognitive processing.
• Reduced mPFC activity: Activity drops in the medial prefrontal cortex, the region most tied to negative self-evaluation.
• Increased entropy: Overall brain signal complexity and variability rise, reflecting a shift away from the rigid, repetitive patterns seen in depression.

According to a StatPearls clinical reference on ketamine, the drug's pharmacology involves NMDA receptor antagonism and downstream effects on glutamate signaling that are consistent with the network-level changes observed on fMRI.

What the Subjective Experience Reflects

The DMN disruption maps closely onto what patients describe during ketamine treatment. A sense of detachment from the usual internal narrative reflects loosening DMN connectivity. The feeling that habitual worry and self-criticism have temporarily lifted corresponds to reduced mPFC activity. An expanded or unfamiliar quality of consciousness aligns with increased between-network connectivity and entropy. The sense of fresh perspective many patients describe after treatment may reflect the brain's reorganization into less rigid DMN patterns.

Post-Treatment Normalization

In patients who respond to ketamine, DMN connectivity begins to normalize in the hours and days following treatment. The hyperconnectivity that characterized the depressive state gives way to more typical patterns, associated with reduced rumination, improved ability to engage with external activities and relationships, greater cognitive flexibility, and reduced intensity of negative self-referential thought. This normalization persists beyond ketamine's acute pharmacological window, suggesting the drug triggers a lasting reorganization of network dynamics rather than simply suppressing symptoms while active in the system.

Depression as a Network-Wide Disorder

The DMN does not operate alone. Depression involves disrupted interactions among several large-scale brain networks:

• Salience network (anterior insula and dorsal anterior cingulate cortex): Determines which internal and external signals deserve attention. Altered function here may contribute to the brain prioritizing negative internal signals.
• Central executive network (dorsolateral prefrontal cortex and posterior parietal cortex): Supports working memory, attention, and goal-directed behavior. Reduced activation here corresponds to difficulties with concentration and motivation.
• Affective network (amygdala and related limbic structures): Governs emotional processing and shows heightened reactivity to negative stimuli in depression.

Ketamine appears to modulate interactions among all of these networks, not just the DMN. By disrupting the DMN's pathological dominance and rebalancing how these networks communicate, ketamine may restore the flexible, adaptive brain function that depression impairs.

Clinical Implications

Timing of Psychotherapy

The period after ketamine treatment, when the DMN has been disrupted and is reorganizing, may represent a useful window for psychotherapeutic work. Therapies that target rumination and rigid cognitive patterns, such as cognitive behavioral therapy and mindfulness-based cognitive therapy, may be more effective when delivered during this window of enhanced neural flexibility. This principle underlies ketamine-assisted psychotherapy (KAP), which pairs structured therapy sessions with ketamine treatment.

Predicting Treatment Response

DMN connectivity measured before treatment with resting-state fMRI has shown preliminary promise as a biomarker for predicting who will respond to ketamine. Patients with the most pronounced DMN hyperconnectivity at baseline may be the most likely to benefit from ketamine's network-disrupting effects, though this finding needs replication in larger studies before it can guide clinical decisions.

Convergence With Other Treatments

The DMN framework reveals overlap between ketamine and other treatments known to modulate this network, including psilocybin, meditation, electroconvulsive therapy, and transcranial magnetic stimulation. Despite different mechanisms, these interventions appear to converge on disrupting pathological DMN patterns, suggesting DMN modulation may be a shared pathway across diverse antidepressant treatments. Preparation and environment also shape how a person responds to treatment; see our guide on set and setting for more on this.